Dr. Heimowitz is an interventional and general cardiologist at Mount Sinai Medical Center. He also a Fellow of both the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

A graduate of the University of Florida, Dr. Heimowitz received his D.O. degree at Nova Southeastern University College of Osteopathic Medicine, and interned in Internal Medicine at the University of Medicine and Dentistry of New Jersey in Camden, N.J. Dr. Heimowitz completed his Internal Medicine residency at Mount Sinai, as well as Fellowships in Cardiology and Interventional Cardiology. During his post-graduate training at Mount Sinai, Dr. Heimowitz was named Cardiology Fellow of the Year, Outstanding Resident of the Year, and Internal Medicine Resident of the Year, and Chief Resident for Internal Medicine and Chief Fellow for Cardiology.

Among his numerous medical appointments, Dr. Heimowitz most recently served on Mount Sinai’s Academic Affairs Committee, which oversees various issues relating to the hospital’s teaching program, and the Multidisciplinary Residency Review Committee, which assesses the medical education program and considers improvements in patient management and interaction between specialties.

His numerous research projects and presentations have included the Trial to Assess Chelation Therapy (TACT); the evaluation of multi-vessel percutaneous intervention versus coronary artery bypass among diabetic patients (The Freedom Trial); Phase 3 Trial to Evaluate Safety and Efficacy of Novel Pacemaker System in Patients with Heart Failure (Fix HF-5); as well as many others. Dr. Heimowitz is Board Certified in Interventional Cardiology, Cardiovascular Diseases, Adult Echocardiography and Nuclear Cardiology.

*This physician is employed by Mount Sinai Medical Center